Pages that link to "Q28580132"

The following pages link to CD36 is a novel serum amyloid A (SAA) receptor mediating SAA binding and SAA-induced signaling in human and rodent cells (Q28580132):

Displaying 48 items.

• Serum Amyloid A Activates the NLRP3 Inflammasome via P2X7 Receptor and a Cathepsin B-Sensitive Pathway (Q28236043) (← links)
• Serum amyloid A induces interleukin-33 expression through an IRF7-dependent pathway (Q28239055) (← links)
• Serum amyloid A in atherosclerosis (Q28242590) (← links)
• Endogenous Acute Phase Serum Amyloid A Lacks Pro-Inflammatory Activity, Contrasting the Two Recombinant Variants That Activate Human Neutrophils through Different Receptors (Q28289800) (← links)
• Particle-induced pulmonary acute phase response may be the causal link between particle inhalation and cardiovascular disease (Q28385471) (← links)
• Luminal Lipid Regulates CD36 Levels and Downstream Signaling to Stimulate Chylomicron Synthesis (Q28578553) (← links)
• Comparative Studies of Vertebrate Platelet Glycoprotein 4 (CD36) (Q28686335) (← links)
• SAA drives proinflammatory heterotypic macrophage differentiation in the lung via CSF-1R-dependent signaling (Q33576194) (← links)
• Human SR-BII mediates SAA uptake and contributes to SAA pro-inflammatory signaling in vitro and in vivo (Q33579601) (← links)
• Structure and Expression of Different Serum Amyloid A (SAA) Variants and their Concentration-Dependent Functions During Host Insults (Q33604867) (← links)
• Class B scavenger receptor types I and II and CD36 mediate bacterial recognition and proinflammatory signaling induced by Escherichia coli, lipopolysaccharide, and cytosolic chaperonin 60 (Q33903801) (← links)
• High-density lipoprotein loses its anti-inflammatory capacity by accumulation of pro-inflammatory-serum amyloid A. (Q34157008) (← links)
• Transmission of systemic AA amyloidosis in animals (Q34388221) (← links)
• Regulation of platelet function by class B scavenger receptors in hyperlipidemia (Q34397435) (← links)
• S100A12 suppresses pro-inflammatory, but not pro-thrombotic functions of serum amyloid A. (Q34701317) (← links)
• Acute-phase serum amyloid a in osteoarthritis: regulatory mechanism and proinflammatory properties (Q34776878) (← links)
• OxLDL or TLR2-induced cytokine response is enhanced by oxLDL-independent novel domain on mouse CD36 (Q34803791) (← links)
• Human serum amyloid A3 (SAA3) protein, expressed as a fusion protein with SAA2, binds the oxidized low density lipoprotein receptor. (Q35146801) (← links)
• Oxidized low-density lipoprotein-dependent platelet-derived microvesicles trigger procoagulant effects and amplify oxidative stress (Q35872535) (← links)
• Serum Amyloid A Induces Toll-Like Receptor 2-Dependent Inflammatory Cytokine Expression and Atrophy in C2C12 Skeletal Muscle Myotubes (Q35897585) (← links)
• Serum amyloid A in uremic HDL promotes inflammation (Q35917487) (← links)
• A new role for the P2X7 receptor: a scavenger receptor for bacteria and apoptotic cells in the absence of serum and extracellular ATP (Q35987687) (← links)
• Molecular inflammation and adipose tissue matrix remodeling precede physiological adaptations to pregnancy (Q36312445) (← links)
• Antagonism of scavenger receptor CD36 by 5A peptide prevents chronic kidney disease progression in mice independent of blood pressure regulation. (Q36707848) (← links)
• Structure of serum amyloid A suggests a mechanism for selective lipoprotein binding and functions: SAA as a hub in macromolecular interaction networks. (Q36723137) (← links)
• Class B scavenger receptor types I and II and CD36 targeting improves sepsis survival and acute outcomes in mice. (Q37383254) (← links)
• Serum amyloid A and pairing formyl peptide receptor 2 are expressed in corneas and involved in inflammation-mediated neovascularization (Q37729400) (← links)
• Damage-associated molecular patterns and their receptors in upper airway pathologies (Q38106874) (← links)
• TLR2 & Co: a critical analysis of the complex interactions between TLR2 and coreceptors (Q38132733) (← links)
• The cytokine-serum amyloid A-chemokine network (Q38705721) (← links)
• Synthetic Amphipathic Helical Peptides Targeting CD36 Attenuate Lipopolysaccharide-Induced Inflammation and Acute Lung Injury (Q39674456) (← links)
• Intravenous cell therapy for acute renal failure with serum amyloid A protein-reprogrammed cells (Q39695145) (← links)
• Interleukin-17A-induced production of acute serum amyloid A by keratinocytes contributes to psoriasis pathogenesis (Q41017479) (← links)
• CD36 in chronic kidney disease: novel insights and therapeutic opportunities (Q41935783) (← links)
• Curcumin analogues as selective fluorescence imaging probes for brown adipose tissue and monitoring browning. (Q42494610) (← links)
• Diabetes insipidus contributes to traumatic brain injury pathology via CD36 neuroinflammation (Q42920728) (← links)
• Serum Amyloid A3 is a High-Density Lipoprotein-associated Acute Phase Protein (Q47287451) (← links)
• Serum amyloid A: an ozone-induced circulating factor with potentially important functions in the lung-brain axis (Q47756327) (← links)
• Feline serum amyloid A protein as an endogenous Toll-like receptor 4 agonist (Q47785832) (← links)
• Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis (Q48109847) (← links)
• Deposition, Clearance, and Reinduction of Amyloid A Amyloid in Interleukin 1 Receptor Antagonist Knockout Mice (Q51548302) (← links)
• Systemic AA amyloidosis in a patient with lung metastasis from renal cell carcinoma. (Q53149012) (← links)
• Apolipoprotein A-II induces acute-phase response associated AA amyloidosis in mice through conformational changes of plasma lipoprotein structure. (Q55089258) (← links)
• Dysfunctional high-density lipoprotein activates toll-like receptors via serum amyloid A in vascular smooth muscle cells (Q64069819) (← links)
• High-density lipoprotein inhibits serum amyloid A-mediated reactive oxygen species generation and NLRP3 inflammasome activation (Q89433895) (← links)
• CD36 tango in cancer: signaling pathways and functions (Q92604883) (← links)
• Serum amyloid A1 mediates myotube atrophy via Toll-like receptors (Q92810873) (← links)
• Recent Progress on Lipid Intake and Chronic Kidney Disease (Q94553911) (← links)